Gene therapy against an experimental glioma using adeno-associated virus vectors

Gene Therapy

Volumn 3, Issue 11, 1996, Pages 957-964

  Okada, H ^a   Miyamura, K ^b   Itoh, T ^b   Hagiwara, M ^c   Wakabayashi, T ^a   Mizuno, M ^a   Colosi, P ^d   Kurtzman, G ^d   Yoshida, J ^a,c  

^a Department of Neurosiirgery ^*  (Japan)

^b Department of Internal Medicine   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Avigen Inc   (United States)

Author keywords

Adeno associated virus; Ganciclovir; Gene therapy; Glioma; Herpes simplex; Thymidine kinase

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 2; THYMIDINE KINASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CELL CULTURE; CISTRON; CONTROLLED STUDY; DOSE RESPONSE; GENE THERAPY; GLIOMA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOTAXIC SURGERY; VIRUS TITRATION;

ANIMALS; ANTIVIRAL AGENTS; BRAIN; CELL TRANSFORMATION, VIRAL; DEPENDOVIRUS; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIOMA; HERPESVIRUS 1, HUMAN; HUMANS; INTERLEUKIN-2; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

ADENO-ASSOCIATED VIRUS; ANIMALIA; HERPES; MUS MUSCULUS; SIMPLEXVIRUS;

EID: 0029990867     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Berns KI, Linden RM. The cryptic life style of adeno-associated virus. Bioessays 1995; 17: 237-245.
2. Lebkowski JS, McNally MM, Okarma TB, Lerch LB. Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 1988; 8: 3988-3996.
3. Srivastava A. Parvovirus-based vectors for human gene therapy. Blood Cells 1994; 20: 531-536.
4. Hermonat PL et al. Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated type 2 mutants. J Virol 1984; 51: 329-339.
5. Tratschin JD, Miller IL, Carter BJ. Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol 1984; 51: 611-619.
6. Samulski RJ, Chang LS, Shenk T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol 1987; 61: 3096-3101.
7. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses, normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
8. Goodman S et al. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 1994; 84: 1492-1500.
9. Miller JL et al. Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc Natl Acad Ssi USA 1994; 91: 10183-10187.
10. Ponnazhagan S, Nallan M, Srivastava A. Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. J Exp Med 1994; 179: 733-738.
11. Zhou SZ et al. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 1994; 179: 1867-1875.
12. Chatterjee S, Johnson PR, Wong KKJr. Dual-target inhibition of HTV-1 in vitro by means of an adeno-associated virus antisense vector. Science 1992; 258: 1485-1488.
13. - channels by protein kinase A corrected by insertion of CFTR. Nature 1992; 358: 581-584.
14. Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993; 90: 10613-10617
15. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
16. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
17. Culver KW et al. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1994; 5: 343-379.
18. Oldfield EH et al. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993; 4: 39-69
19. Ram Z et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83-88.
20. Chen SH et al. Gene therapy for brain tumors, regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994; 91: 3054-3057.
21. Perez-Cruet MJ et al. Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res 1994; 39: 506-511.
22. Yang Y et al. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
23. Dickson D. UK scientists test liposome gene therapy technique. Nature 1993; 365: 4.
24. Wu JK et al. Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 1994; 35: 1094-1102.
25. Badie B, Hunt K, Economou JS, Black KL. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery 1994; 35: 910-915.
26. Ram Z et al. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 1994; 81: 256-260.
27. Barba D, Hardin J, Sadelain M, Gage FH. Development of antitumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 1994; 91: 4348-4352.
28. Ram Z et al. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. J Neurosurg 1994; 80: 535-540.
29. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors only occurs in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
30. Cornetta K et al. Amphotrophic murine leukemia retrovirus is not an acute pathogen for primates Hum Gene Ther 1990; 1: 15-30.
31. Colosi P, Elliger S, Elliger C, Kurtzman G. AAV vectors can be efficiently produced without a helper virus Blood 1995; 86 (Suppl. 1): 627a.
32. Ghattas IK, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 1991; 11: 5848-5849.
33. Morgan RA et al. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res 1992; 20: 1293-1299.